header
Image from OpenLibrary

Tyrosine kinase inhibitors response evaluation in phylladelphia positive chronic myeloginous leukemia patients from january 2009 to january 2014 : A retrospective study / Ibraheem Hassan Kabeel ; Supervised Emad Hamada , Mostafa Elhaddad , Moustafa Aldaly

By: Contributor(s): Material type: TextTextLanguage: English Publication details: Cairo : Ibraheem Hassan Kabeel , 2015Description: 131 P. : charts ; 25cmOther title:
  • دراسة استعادية لتقييم تأثير الأدوية المثبطة لانزيم التايروزين كاينيز في حالات سرطان لدم الميلودي المزمن موجبة كروموزوم فيلاديلفيا [Added title page title]
Subject(s): Available additional physical forms:
  • Issued also as CD
Dissertation note: Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Oncology (Radiation) Summary: The cause of chronic myeloid leukemia is a constitutively active BCR-ABL tyrosine kinase enzyme. Imatinib,Dasatinib and Nilotinib inhibit this kinase .We analyzed the results of response in patients of ph+ve CML who attended Kasr El Aini center of radiation oncology during the period Jan.2009 to Jan 2014 .We analyzed hematologic and molecular response, together with progression free survival and adverse events.Imatinib induced a hematological response in almost all cases, but its molecular response was less. Dasatinib and Nilotinib were used as a second line after Imatinib failure, suboptimal response, or intolerable adverse effects
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Home library Call number Copy number Status Date due Barcode
Thesis Thesis قاعة الرسائل الجامعية - الدور الاول المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.11.23.M.Sc.2015.Ib.T (Browse shelf(Opens below)) Not for loan 01010110068460000
CD - Rom CD - Rom مخـــزن الرســائل الجـــامعية - البدروم المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.11.23.M.Sc.2015.Ib.T (Browse shelf(Opens below)) 68460.CD Not for loan 01020110068460000

Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Oncology (Radiation)

The cause of chronic myeloid leukemia is a constitutively active BCR-ABL tyrosine kinase enzyme. Imatinib,Dasatinib and Nilotinib inhibit this kinase .We analyzed the results of response in patients of ph+ve CML who attended Kasr El Aini center of radiation oncology during the period Jan.2009 to Jan 2014 .We analyzed hematologic and molecular response, together with progression free survival and adverse events.Imatinib induced a hematological response in almost all cases, but its molecular response was less. Dasatinib and Nilotinib were used as a second line after Imatinib failure, suboptimal response, or intolerable adverse effects

Issued also as CD

There are no comments on this title.

to post a comment.